ETHEMA HEALTH Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ETHEMA HEALTH Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.02M | May 23, 2025 |
| FY2024 | Dec 31, 2023 | $5.34M | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $4.82M | May 7, 2024 |
| FY2022 | Dec 31, 2021 | $1.94M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $339.0K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $359.9K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $432.5K | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $929.4K | Apr 22, 2019 |
| FY2015 | Dec 31, 2015 | $3.14M | Apr 18, 2016 |
| FY2015 | Dec 31, 2014 | $3.42M | Apr 18, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $4.71M | Mar 28, 2014 |
| FY2013 | Dec 31, 2012 | $4.49M | Mar 28, 2014 |
| FY2012 | Dec 31, 2011 | ($1.03M) | Apr 1, 2013 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.17M) | May 23, 2025 |
| FY2024 | Dec 31, 2023 | $1.01M | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $295.2K | May 7, 2024 |
| FY2022 | Dec 31, 2021 | ($1.54M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.08M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($14.96M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($8.18M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | ($1.37M) | Apr 22, 2019 |
| FY2018 | Dec 31, 2016 | ($260.7K) | Apr 22, 2019 |
| FY2016 | Dec 31, 2015 | ($1.16M) | Apr 17, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.33M) | May 23, 2025 |
| FY2024 | Dec 31, 2023 | ($541.9K) | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $489.1K | May 7, 2024 |
| FY2022 | Dec 31, 2021 | $2.1K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($163.3K) | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($4.20M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($2.88M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | ($1.45M) | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | ($790.9K) | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | ($450.2K) | Apr 17, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($455.7K) | May 23, 2025 |
| FY2024 | Dec 31, 2023 | ($530.2K) | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $1.58M | May 7, 2024 |
| FY2022 | Dec 31, 2021 | ($85.6K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($102.0K) | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($2.90M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($1.46M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | ($4.64M) | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | ($4.1K) | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | ($966.5K) | Apr 17, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $60.3K | May 23, 2025 |
| FY2024 | Dec 31, 2023 | $40.6K | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $315.8K | May 7, 2024 |
| FY2021 | Dec 31, 2021 | $132.8K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($120.0K) | Apr 15, 2021 |
| FY2018 | Dec 31, 2017 | $2.96M | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | ($110.0K) | Apr 18, 2018 |
| FY2015 | Dec 31, 2015 | $27.5K | Apr 18, 2016 |
| FY2015 | Dec 31, 2014 | $57.0K | Apr 18, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $12.16M | May 23, 2025 |
| FY2024 | Dec 31, 2023 | $11.52M | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $6.56M | May 7, 2024 |
| FY2022 | Dec 31, 2021 | $6.55M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.82M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $3.21M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $12.67M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $12.27M | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | $460.1K | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $291.8K | Apr 17, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $19.62M | May 23, 2025 |
| FY2024 | Dec 31, 2023 | $17.72M | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $15.40M | May 7, 2024 |
| FY2022 | Dec 31, 2021 | $16.01M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $18.45M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $23.23M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $20.39M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $14.04M | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | $3.64M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $3.42M | Apr 17, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($7.46M) | May 23, 2025 |
| FY2024 | Dec 31, 2023 | ($6.20M) | May 23, 2025 |
| FY2024 | Dec 31, 2022 | ($9.23M) | May 23, 2025 |
| FY2022 | Dec 31, 2021 | ($10.68M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($15.73M) | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($20.02M) | Apr 15, 2021 |
| FY2020 | Dec 31, 2018 | ($7.72M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | ($1.78M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2016 | ($3.18M) | Apr 22, 2019 |
| FY2017 | Dec 31, 2015 | ($3.13M) | Apr 18, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($44.42M) | May 23, 2025 |
| FY2024 | Dec 31, 2023 | ($42.36M) | May 23, 2025 |
| FY2023 | Dec 31, 2022 | ($43.48M) | May 7, 2024 |
| FY2022 | Dec 31, 2021 | ($44.10M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($42.46M) | Apr 14, 2022 |
| FY2019 | Dec 31, 2019 | ($45.49M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2018 | ($30.53M) | Apr 22, 2019 |
| FY2017 | Dec 31, 2017 | ($16.97M) | Apr 18, 2018 |
| FY2016 | Dec 31, 2016 | ($20.98M) | Apr 17, 2017 |
| FY2015 | Dec 31, 2015 | ($20.72M) | Apr 18, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $244.8K | May 23, 2025 |
| FY2024 | Dec 31, 2023 | $68.6K | May 23, 2025 |
| FY2023 | Dec 31, 2022 | $140.8K | May 7, 2024 |
| FY2022 | Dec 31, 2021 | $48.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $90.5K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $3.0K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $24.7K | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $339 | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | $4.8K | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $174 | Apr 17, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | May 23, 2025 |
| FY2024 | Dec 31, 2023 | 0 | May 23, 2025 |
| FY2018 | Dec 31, 2018 | 0 | Apr 22, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 22, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | May 23, 2025 |
| FY2024 | Dec 31, 2023 | 0 | May 23, 2025 |
| FY2018 | Dec 31, 2018 | 0 | Apr 22, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 22, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 7.73B | May 23, 2025 |
| FY2024 | Dec 31, 2023 | 3.73B | May 23, 2025 |
| FY2023 | Dec 31, 2022 | 3.73B | May 7, 2024 |
| FY2022 | Dec 31, 2021 | 3.58B | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 2.21B | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | 155.48M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 124.30M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | 123.24M | Apr 22, 2019 |
| FY2017 | Dec 31, 2016 | 48.74M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | 47.74M | Apr 17, 2017 |